These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 9548508

  • 1. Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells.
    Cichy J, Rose-John S, Potempa J, Pryjma J, Travis J.
    J Immunol; 1997 Dec 01; 159(11):5648-53. PubMed ID: 9548508
    [Abstract] [Full Text] [Related]

  • 2. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M, Richards CD, Gauldie J.
    Cytokine; 1995 Aug 01; 7(6):503-9. PubMed ID: 8580365
    [Abstract] [Full Text] [Related]

  • 3. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P, Tóth S, Rose-John S, Madurka I, Fejér G, Szalai C, Falus A.
    Cytokine; 1998 Aug 01; 10(8):620-6. PubMed ID: 9722935
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes.
    Paysant J, Blanqué R, Vasse M, Soria C, Soria J, Gardner CR.
    Cytokine; 2000 Jun 01; 12(6):774-9. PubMed ID: 10843763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
    Gabay C, Silacci P, Genin B, Mentha G, Le Coultre C, Guerne PA.
    Eur J Immunol; 1995 Aug 01; 25(8):2378-83. PubMed ID: 7545121
    [Abstract] [Full Text] [Related]

  • 7. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.
    Hooper WC, Phillips DJ, Evatt BL.
    Thromb Haemost; 1997 May 01; 77(5):1014-9. PubMed ID: 9184420
    [Abstract] [Full Text] [Related]

  • 8. Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage.
    Thabard W, Barillé S, Collette M, Harousseau JL, Rapp MJ, Bataille R, Amiot M.
    Clin Cancer Res; 1999 Oct 01; 5(10):2693-7. PubMed ID: 10537331
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May 01; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M, Blinn G, Solem F, Fischer M, Meyer zum Büschenfelde KH, Rose-John S.
    J Immunol; 1998 Oct 01; 161(7):3575-81. PubMed ID: 9759879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 15. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
    Yoshida S, Harada T, Iwabe T, Taniguchi F, Mitsunari M, Yamauchi N, Deura I, Horie S, Terakawa N.
    Hum Reprod; 2004 Aug 01; 19(8):1821-5. PubMed ID: 15166129
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.
    Haselmann J, Goppelt-Struebe M.
    Cytokine; 1997 Mar 01; 9(3):199-205. PubMed ID: 9126708
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
    Gaillard J, Pugnière M, Tresca J, Mani J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Sep 01; 10(3):337-44. PubMed ID: 10477390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.